CY1122834T1 - Παραγωγα χλωρινης χρησιμα στη φωτοδυναμικη θεραπεια και τη διαγνωση - Google Patents
Παραγωγα χλωρινης χρησιμα στη φωτοδυναμικη θεραπεια και τη διαγνωσηInfo
- Publication number
- CY1122834T1 CY1122834T1 CY20201100411T CY201100411T CY1122834T1 CY 1122834 T1 CY1122834 T1 CY 1122834T1 CY 20201100411 T CY20201100411 T CY 20201100411T CY 201100411 T CY201100411 T CY 201100411T CY 1122834 T1 CY1122834 T1 CY 1122834T1
- Authority
- CY
- Cyprus
- Prior art keywords
- diagnosis
- photodynamic therapy
- therapy
- sodium salt
- derivatives useful
- Prior art date
Links
- 238000003745 diagnosis Methods 0.000 title abstract 3
- 238000002428 photodynamic therapy Methods 0.000 title abstract 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical class [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 title 1
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 abstract 4
- 238000001514 detection method Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000002622 cytoluminescent therapy Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0036—Porphyrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- AIDS & HIV (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
Abstract
Η παρούσα εφεύρεση αφορά άλας νατρίου χλωρίνης e4 και μία διεργασία για την παρασκευή αυτού. Το άλας νατρίου χλωρίνης e4 είναι κατάλληλο για χρήση στη φωτοδυναμική θεραπεία, στη θεραπεία κυτταροφωταύγειας (cytoluminescent therapy) και στη φωτοδυναμική διάγνωση, παραδείγματος χάριν για τη θεραπεία ή την ανίχνευση ενός όγκου. Η παρούσα εφεύρεση αφορά επίσης μία φαρμακευτική σύνθεση που περιλαμβάνει άλας νατρίου χλωρίνης e4, τη χρήση του άλατος νατρίου χλωρίνης e4 στην παρασκευή ενός φωτοθεραπευτικού ή φωτοδιαγνωστικού παράγοντα, και μία μέθοδο φωτοδυναμικής θεραπείας, θεραπείας κυτταροφωταύγειας ή φωτοδυναμική διάγνωση, παραδείγματος χάριν για τη θεραπεία ή την ανίχνευση ενός όγκου.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1222544.7A GB201222544D0 (en) | 2012-12-14 | 2012-12-14 | Photodynamic therapy and diagnosis |
| GB1309337.2A GB2514408A (en) | 2013-05-23 | 2013-05-23 | Photodynamic Therapy and Diagnosis |
| PCT/GB2013/053285 WO2014091241A1 (en) | 2012-12-14 | 2013-12-13 | Chlorin derivative useful in photodynamic therapy and diagnosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1122834T1 true CY1122834T1 (el) | 2021-05-05 |
Family
ID=49958497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20201100411T CY1122834T1 (el) | 2012-12-14 | 2020-05-05 | Παραγωγα χλωρινης χρησιμα στη φωτοδυναμικη θεραπεια και τη διαγνωση |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20150315202A1 (el) |
| EP (1) | EP2931728B1 (el) |
| JP (1) | JP6396919B2 (el) |
| KR (1) | KR102242404B1 (el) |
| CN (2) | CN110003225A (el) |
| AU (2) | AU2013357030B2 (el) |
| CA (1) | CA2894968C (el) |
| CY (1) | CY1122834T1 (el) |
| DK (1) | DK2931728T3 (el) |
| ES (1) | ES2791004T3 (el) |
| HK (1) | HK1216534A1 (el) |
| HR (1) | HRP20200734T1 (el) |
| HU (1) | HUE048861T2 (el) |
| IL (1) | IL239347B (el) |
| LT (1) | LT2931728T (el) |
| ME (1) | ME03725B (el) |
| MY (1) | MY180320A (el) |
| PH (1) | PH12015501341B1 (el) |
| PL (1) | PL2931728T3 (el) |
| PT (1) | PT2931728T (el) |
| RS (1) | RS60225B1 (el) |
| SG (1) | SG11201504595UA (el) |
| SI (1) | SI2931728T1 (el) |
| WO (1) | WO2014091241A1 (el) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180228703A1 (en) | 2015-08-08 | 2018-08-16 | Chl Industries, Llc | Improved Hyaluronan and Modified-Hyaluronan in Biomedical Applications |
| RU2753402C1 (ru) * | 2020-04-15 | 2021-08-16 | Федеральное государтвенное бюджетное учреждение "Российский научный центр радиологии и хирургических технологий имени академика А.М. Гранова" Министерства здравоохранения Российской Федерации | Способ фотодинамической терапии при лечении нерезекабельной аденокарциномы внепеченочных желчных протоков |
| GB202018667D0 (en) * | 2020-11-26 | 2021-01-13 | Rmw Cho Group Ltd | Photodynamic therapy and diagnosis |
| CN113527319B (zh) * | 2021-06-10 | 2023-03-07 | 中国人民解放军海军军医大学 | 一种新型二氢卟吩e4衍生物及其药学上可接受的盐和制备方法与应用 |
| GB202217863D0 (en) | 2022-11-28 | 2023-01-11 | Rmw Cho Group Ltd | Novel compounds |
| GB202217864D0 (en) | 2022-11-28 | 2023-01-11 | Rmw Cho Group Ltd | Novel compounds |
| WO2024115524A1 (en) | 2022-11-28 | 2024-06-06 | Rmw Cho Group Limited | Porphyrin and phosphonium-porphyrin based compounds for photodynamic therapy and diagnostics |
| WO2024115525A2 (en) | 2022-11-28 | 2024-06-06 | Rmw Cho Group Limited | Novel compounds |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5002962A (en) * | 1988-07-20 | 1991-03-26 | Health Research, Inc. | Photosensitizing agents |
| JP2963178B2 (ja) * | 1990-09-27 | 1999-10-12 | 株式会社エス・エル・ティ・ジャパン | 水溶性フェオホーバイドａの製造方法 |
| CN1148184C (zh) * | 1999-10-28 | 2004-05-05 | 上海复旦张江生物医药股份有限公司 | 光动力治疗肿瘤药物组合物 |
| RU2183956C1 (ru) * | 2001-03-30 | 2002-06-27 | Общество с ограниченной ответственностью "РАДА-ФАРМА" | Фотосенсибилизатор и способ его получения |
| US20050020559A1 (en) * | 2001-10-03 | 2005-01-27 | Robinson Byron C | Chlorin photosensitizing agents for use in photodynamic therapy |
| CN100443485C (zh) * | 2005-04-08 | 2008-12-17 | 吴华君 | 叶绿酸合铁钠盐衍生物、制备方法及用途 |
| GB0718878D0 (en) * | 2007-09-28 | 2007-11-07 | Photo Diagnostic Devices Pdd L | Photodynamic Theraphy and diagnosis |
-
2013
- 2013-12-13 US US14/651,271 patent/US20150315202A1/en not_active Abandoned
- 2013-12-13 DK DK13821500.9T patent/DK2931728T3/da active
- 2013-12-13 KR KR1020157017350A patent/KR102242404B1/ko active IP Right Grant
- 2013-12-13 SI SI201331722T patent/SI2931728T1/sl unknown
- 2013-12-13 PL PL13821500T patent/PL2931728T3/pl unknown
- 2013-12-13 ME MEP-2020-94A patent/ME03725B/me unknown
- 2013-12-13 MY MYPI2015001526A patent/MY180320A/en unknown
- 2013-12-13 ES ES13821500T patent/ES2791004T3/es active Active
- 2013-12-13 LT LTEP13821500.9T patent/LT2931728T/lt unknown
- 2013-12-13 CN CN201811587683.XA patent/CN110003225A/zh active Pending
- 2013-12-13 AU AU2013357030A patent/AU2013357030B2/en not_active Ceased
- 2013-12-13 CN CN201380072967.4A patent/CN105008372B/zh active Active
- 2013-12-13 EP EP13821500.9A patent/EP2931728B1/en active Active
- 2013-12-13 CA CA2894968A patent/CA2894968C/en active Active
- 2013-12-13 RS RS20200533A patent/RS60225B1/sr unknown
- 2013-12-13 JP JP2015547147A patent/JP6396919B2/ja active Active
- 2013-12-13 SG SG11201504595UA patent/SG11201504595UA/en unknown
- 2013-12-13 PT PT138215009T patent/PT2931728T/pt unknown
- 2013-12-13 WO PCT/GB2013/053285 patent/WO2014091241A1/en active Application Filing
- 2013-12-13 HU HUE13821500A patent/HUE048861T2/hu unknown
-
2015
- 2015-06-11 IL IL239347A patent/IL239347B/en active IP Right Grant
- 2015-06-15 PH PH12015501341A patent/PH12015501341B1/en unknown
-
2016
- 2016-04-20 HK HK16104558.8A patent/HK1216534A1/zh unknown
-
2018
- 2018-12-20 AU AU2018282411A patent/AU2018282411A1/en not_active Abandoned
-
2020
- 2020-05-05 CY CY20201100411T patent/CY1122834T1/el unknown
- 2020-05-07 HR HRP20200734TT patent/HRP20200734T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1122834T1 (el) | Παραγωγα χλωρινης χρησιμα στη φωτοδυναμικη θεραπεια και τη διαγνωση | |
| CY1123991T1 (el) | Δικυκλικες ετεροκυκλικες ενωσεις και χρησεις αυτων στη θεραπεια | |
| CY1124436T1 (el) | Δικυκλικες ετεροκυκλικες ενωσεις και χρησεις αυτων στη θεραπεια | |
| CY1122186T1 (el) | Μεθοδοι θεραπειας καρκινου | |
| CY1123666T1 (el) | Φαρμακευτικες ενωσεις | |
| CY1124810T1 (el) | Συνδυαστικη θεραπεια για τη θεραπευτικη αντιμετωπιση του καρκινου | |
| CY1123627T1 (el) | Παραγωγα διυδροϊμιδαζοπυραζινονης χρησιμα στη θεραπευτικη αντιμετωπιση του καρκινου | |
| CY1120334T1 (el) | Υποκατεστημενης 3-αλλογονοαλυλαμινης αναστολεις ssao και χρησεις αυτων | |
| EA201592200A1 (ru) | Производные сульфамоилпирроламида и их применение в качестве медикаментов для лечения гепатита b | |
| MX2020003174A (es) | Terapia de combinacion que comprende un inhibidor de tor cinasa y un compuesto imid para tratar cancer. | |
| CL2017000290A1 (es) | Inhibidores de la proteína kinasa c y métodos de su uso. | |
| EA201290727A1 (ru) | Пирролбензодиазепины и их конъюгаты | |
| EA201590343A1 (ru) | Алкилпиримидиновые производные для лечения вирусных инфекций и дальнейших заболеваний | |
| PH12016502355A1 (en) | Pharmaceutical composition | |
| EA201490647A1 (ru) | Производные бензотиазол-6-илуксусной кислоты и их применение для лечения вич-инфекции | |
| CY1123043T1 (el) | Συνδυαστικες θεραπειες για την αγωγη ανθεκτικων στη χημειοθεραπεια καρκινων | |
| EA201590941A1 (ru) | Гетероциклические ингибиторы глютаминазы | |
| EA201491854A1 (ru) | Асимметрический синтез соединений спирооксиндола, полезных в качестве терапевтических средств | |
| EA201591924A1 (ru) | Способы лечения злокачественной опухоли с использованием комбинированной терапии с коферментом q10 | |
| WO2016043874A3 (en) | Combination therapy for treating cancer | |
| EA201591378A1 (ru) | Композиции неорганических наночастиц в комбинации с ионизирующим излучением для лечения рака | |
| PH12015502616A1 (en) | Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer | |
| EA201692481A1 (ru) | Комбинация, содержащая глюкокортикоид и edo-s101 | |
| EA201591706A1 (ru) | Солевые формы (s)-хинуклидин-3-ил-(2-(2-(4-фторфенил)тиазол-4-ил)пропан-2-ил)карбамата | |
| EA201892631A1 (ru) | Дигидротестостерон и производные и промоторы дигидротестостерона в лечении рака |